Internal Medicine, Hematology & Oncology · Riverhead, NY
NPI
1073803557
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
750 Old Country Road Building 2
Riverhead, NY, 11901
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
136,343 services
Medicare patients, 2024
1,806
Average age 75
Drug cost, 2024
$10.5M
2,632 prescriptions
Company payments, 2025
$7,651
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yelda Nouri was code J1439 (injection, ferric carboxymaltose, 1 mg), 42,750 times for 49 patients. In total Yelda Nouri billed 136,343 services in 290 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 42,750 | 49 | $0.87 | $37K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 8,100 | 18 | $2.27 | $18K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,600 | 21 | $44.45 | $338K |
| J0897 Injection, denosumab, 1 mg | Office | 5,100 | 56 | $20.48 | $104K |
| J1756 Injection, iron sucrose, 1 mg | Office | 4,400 | 18 | $0.17 | $762 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,850 | 12 | $35.54 | $101K |
| 88185 Surgical Pathology Examination | Office | 2,786 | 115 | $22.18 | $62K |
| 36415 Venipuncture Blood Collection | Office | 2,750 | 1,379 | $8.65 | $24K |
| 85025 Blood Count | Office | 2,696 | 1,366 | $7.60 | $20K |
| 80053 Clinical Chemistry | Office | 2,278 | 1,267 | $10.32 | $24K |
| 84100 Clinical Chemistry | Office | 1,816 | 1,024 | $4.64 | $8,421 |
| 83735 Clinical Chemistry | Office | 1,803 | 1,007 | $6.55 | $12K |
| 83615 Clinical Chemistry | Office | 1,793 | 1,015 | $5.91 | $11K |
| 84550 Clinical Chemistry | Office | 1,776 | 1,006 | $4.42 | $7,846 |
| 99214 Office E&M - Established | Office | 1,654 | 952 | $106.92 | $177K |
By year: 2022 $4.5M for 380,796 services; 2023 $3.0M for 196,532 services; 2024 $2.3M for 136,343 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 2,786 | 115 | $22.18 | $62K |
| 36415 Venipuncture Blood Collection | 2,750 | 1,379 | $8.65 | $24K |
| 85025 Blood Count | 2,696 | 1,366 | $7.60 | $20K |
| 80053 Clinical Chemistry | 2,278 | 1,267 | $10.32 | $24K |
| 84100 Clinical Chemistry | 1,816 | 1,024 | $4.64 | $8,421 |
| 83735 Clinical Chemistry | 1,803 | 1,007 | $6.55 | $12K |
| 83615 Clinical Chemistry | 1,793 | 1,015 | $5.91 | $11K |
| 84550 Clinical Chemistry | 1,776 | 1,006 | $4.42 | $7,846 |
| 82378 Clinical Chemistry | 919 | 500 | $18.55 | $17K |
| 82728 Clinical Chemistry | 893 | 628 | $13.35 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Yelda Nouri prescribed most often to Medicare patients was Anastrozole, with 367 prescriptions and refills. In total Yelda Nouri wrote 2,632 Medicare prescriptions that cost $10.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 367 | 989 | 152 | $5,965 |
| Letrozole Generic | 266 | 715 | 98 | $5,076 |
| Aranesp Darbepoetin Alfa In Polysorbat | 160 | 162 | 32 | $470K |
| Xgeva Denosumab | 96 | 109 | 23 | $293K |
| Eliquis Apixaban | 85 | 89 | 21 | $52K |
| Akynzeo Fosnetupitant/Palonosetron | 75 | 75 | 21 | $88K |
| Ibrance Palbociclib | 72 | 72 | 15 | $1.1M |
| Tamoxifen Citrate Generic | 72 | 193 | 33 | $1,686 |
| Ontruzant Trastuzumab-Dttb | 68 | 68 | Under 11 | $337K |
| Imbruvica Ibrutinib | 63 | 63 | Under 11 | $993K |
| Fulvestrant Generic | 47 | 47 | Under 11 | $66K |
| Kisqali Ribociclib Succinate | 47 | 47 | Under 11 | $634K |
| Ondansetron Odt Ondansetron | 42 | 42 | 35 | $635 |
| Procrit Epoetin Alfa | 41 | 45 | Under 11 | $105K |
| Exemestane Generic | 37 | 85 | 14 | $8,679 |
Brand drugs: 1,334 claims; generic drugs: 1,298 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yelda Nouri $7,651 ($7,651 in general payments such as food, travel and fees) from 5 companies. The largest payer was Daiichi Sankyo Inc. with $5,530.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.